A Novel Anti-Human Syndecan-1 (CD138) Monoclonal Antibody 4B3: Characterization and Application

被引:1
|
作者
Wanping Sun1
2Physiology Department of Basic Medical School
3Stem Cell Research Laboratory of Jiangsu Province
机构
关键词
syndecan-1(CD138); monoclonal antibody; multiple myeloma;
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Syndecan-1 (CD138), a member of integral membrane heparin sulfate proteoglycans, is an essential matrix receptor for maintaining the normal morphological phenotypes. In this study, we generated a specific mouse anti-human syndecan-1 monoclonal antibody (mAb) 4B3 and identified it by competition assay with the available syndecan-1 mAb (BB4). Stained by 4B3, the expression of syndecan-1 was detected on tumor cell lines, such as 8226, U266, XG-1, XG-2, Daudi and Jurkat. The expression was also found on neuron stem cells. It was established that 4B3 mAb could inhibit XG-1 and XG-2 proliferation. The data not only determined that 4B3 mAb was a functional anti-human syndecan-1 mAb, but also indicated that syndecan-1 might be a valuable surface antigen and play an important role in regulation of tumor pathology and differentiation of neural stem cells. This novel antibody 4B3 may be value of study of tumor proliferation/survival mechanism and contributes to diagnosis and treatment of diverse diseases.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [1] A novel anti-human Syndecan-1(CD138) monoclonal antibody 4B3: Characterization and application
    Wanping Sun
    Fengming Wang
    Fang Xie
    Guoqing Wang
    Jin Sun
    Gehua Yu
    Yuhua Qiu
    Xueguang Zhang
    CELLULAR & MOLECULAR IMMUNOLOGY, 2007, 4 (03) : 209 - 214
  • [2] Anti-human CD138 monoclonal antibodies and their bispecific formats: generation and characterization
    Chen, Dan
    Zou, Jianxuan
    Zong, Yunhui
    Meng, Huimin
    An, Gangli
    Yang, Lin
    IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2016, 38 (03) : 175 - 183
  • [3] Role of syndecan-1 (CD138) in cell survival of human urothelial carcinoma
    Shimada, Keiji
    Nakamura, Mitsutoshi
    De Velasco, Marco A.
    Tanaka, Motoyoshi
    Ouji, Yukiteru
    Miyake, Makito
    Fujimoto, Kiyohide
    Hirao, Kazuya
    Konishi, Noboru
    CANCER SCIENCE, 2010, 101 (01) : 155 - 160
  • [4] Syndecan-1 (CD138) Regulates Competition Between Antibody Secreting Cells for Survival
    Fooksman, David R.
    McCarron, Mark
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [5] Syndecan-1 (CD138) expression in human non-Hodgkin lymphomas
    Sebestyén, A
    Berczi, L
    Mihalik, R
    Paku, S
    Matolcsy, A
    Kopper, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (02) : 412 - 419
  • [6] Soluble Syndecan-1 (CD138) - A Novel Biomarker in Patients With Inflammatory Bowel Disease
    Yablecovitch, Doron
    Stein, Assaf
    Naftali, Timna
    Gabay, Gila
    Laish, Ido
    Benjaminov, Fabiana
    Konikoff, Fred M.
    GASTROENTEROLOGY, 2013, 144 (05) : S423 - S423
  • [7] Syndecan-1 (CD138) expression in human non-Hodgkin's lymphomas
    Sutcliffe, M
    Oscier, D
    Wright, DH
    BRITISH JOURNAL OF HAEMATOLOGY, 2000, 110 (01) : 239 - 240
  • [8] Syndecan-1 (CD138) antigen targeting using a I-131-labeled anti-CD138 antibody in human breast cancer xenografted nude mice
    Rousseau, C.
    Ruellan, A. L.
    Kraeber-Bodere, F.
    Bernardeau, K.
    Loussouarn, D.
    Campion, L.
    Sai-Maurel, C.
    Faivre-Chauvet, A.
    Wijdenes, J.
    Cherel, M.
    Davodeau, F.
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2008, 23 (04) : 520 - 521
  • [9] Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal Tissues
    Kind, Simon
    Merenkow, Christina
    Buescheck, Franziska
    Moeller, Katharina
    Dum, David
    Chirico, Viktoria
    Luebke, Andreas M.
    Hoeflmayer, Doris
    Hinsch, Andrea
    Jacobsen, Frank
    Goebel, Cosima
    Weidemann, Soeren
    Fraune, Christoph
    Moeller-Koop, Christina
    Hube-Magg, Claudia
    Clauditz, Till S.
    Simon, Ronald
    Sauter, Guido
    Wilczak, Waldemar
    Bawahab, Ahmed Abdulwahab
    Izbicki, Jakob R.
    Perez, Daniel
    Marx, Andreas
    DISEASE MARKERS, 2019, 2019
  • [10] Production and characterization of monoclonal antibodies specific for canine CD138 (syndecan-1) for nuclear medicine preclinical trials on spontaneous tumours
    Diab, M.
    Nguyen, F.
    Berthaud, M.
    Maurel, C.
    Gaschet, J.
    Verger, E.
    Ibisch, C.
    Rousseau, C.
    Cherel, M.
    Abadie, J.
    Davodeau, F.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (03) : 932 - 951